Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20201207049639N8Phase 3Completed
Phase 3, randomised, double-blind trial in hypotension comparing Phenylephrine 5 micrograms with Norepinephrine 5 micrograms (2 arms). Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 2 more. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20201207049639N8.